72 results on '"Nitti V"'
Search Results
2. [Exogenous factors related to chronic bronchitis as determined by multi-center studies in the city of Naples. Presentation and interpretation of the results].
3. [Evaluation of multivariate statistical analysis in the use of markers for the differential diagnosis between bronchopneumopathies and lung tumors].
4. [Primary resistance of mycobacterium tuberculosis (studies related to the triennium 1973-6)].
5. [Ceftizoxime and its place in the context of modern cephalosporins].
6. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
7. P-aminosalicylic acid in the treatment of tuberculosis.
8. [The determination of mycobacterial resistance to Rifampicin with the proportion method. (Technical problems and definition of the critical levels)].
9. [Pulmonary tuberculosis in advanced age. Causes of death and anatomopathologic pictures].
10. [The antimycobacterial activity of rifamycin B diethylamide].
11. [Activity of terizidone in experimental tuberculosis in rabbits].
12. [The activity of Rifampicin in vitro on atypical mycobacteria].
13. [Considerations on current epidemiological and clinical aspects and on therapeutic problems of tuberculosis when first detected].
14. [On the reentrance of former tuberculotics into the working life. (Observations on trends in the field)].
15. [Intermittent treatment with Rifampicin in experimental tuberculosis in guinea pigs].
16. The processes with a chronic footprint in the war period.
17. [The bacterial chemoresistance at the time of admission].
18. [Bactericidal effect of cycloserine in vitro].
19. [Experimental studies of the antimycobacterial activity of Rifampicine].
20. [Problems and prospects of antitubercular chemotherapy at the present time].
21. [Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV].
22. [Qualitative aspects and chronological order of tuberculous manifestations in vaccinated subjects; clinical and bibliographical study].
23. [Rifampicin in tuberculosis. Summary of the observations and discussion].
24. [Antimycobacterial activity of rifamycin SV in vitro].
25. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY].
26. [Observations on the therapeutic activity of ethioniamide].
27. [A new antitubercular drug, tuberculosis I of Domagk].
28. Methods for reactivating quiescent outbreaks.
29. [Case report of a pleuro-pneumonic acute process of Pseudomonas aeruginosa, treated with gentamicin].
30. [Intermittent therapy in tuberculosis].
31. On the clinical-biological physiognomy of primary thysiogenic lobite; morphological and evolutionary aspects of morbid successions.
32. [General aspects of chemoresistance of Mycobacterium tuberculosis and its relation to pathology and therapy].
33. [The action of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 1. Activity of kanamycin alone].
34. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
35. [Morpho-structural aspects of Mycobacterium tuberculosis under the action of various anti-bacterial drugs].
36. [Conditions and methods of appearance of reinfection in vaccination subjects].
37. [In vitro resistance of Mycobacterium tuberculosis to cycloserine].
38. [The activity of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 2. Action of kanamycin associated with other antibacterial agents].
39. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
40. [Observations on the morphology of tubercular mycobacteria studied by the electron microscope].
41. [On the audiotoxic activity of dihydrostreptomycin (audiometric and statistical observations)].
42. [Hematic concentration and urinary elimination of PAS during continuous treatment].
43. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
44. [Trends in the general therapy of chronic aspecific bronchopneumopathies].
45. [Contribution to the knowledge of biologically incapsulated post-pleuritic empyema].
46. [INFLUENCE OF THE STATE OF BACTERIAL AGGREGATION ON THE ACTIVITY OF RIFOMYCIN SV IN VITRO].
47. [Rifomycin SV: a new antibiotic against Mycobacterium tuberculosis. Prelimnary note].
48. [Action of the thioamide of alpha-ethylisonicotinic acid on the morphology of Mycobacterium tuberculosis (research by electron microscopy)].
49. [Therapeutic pneumothorax in physiomechanical equilibrium: bronchospirometric and ergometric aspects].
50. [Bactericidal activity of kanamycin on Mycobacterium tuberculosis in vitro].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.